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MicroRNAs (miRNAs) are short non-coding RNAs that regulate the expression of protein
coding genes of viruses and eukaryotes at the post-transcriptional level. The eukaryotic
genes regulated by miRNAs include those whose products are critical for biological
processes such as cell proliferation, metabolic pathways, immune response, and
development. It is now increasingly recognized that modulation of miRNAs associated
with biological processes is one of the strategies adopted by bacterial pathogens to
survive inside host cells. In this review, we present an overview of the recent findings on
alterations of miRNAs in the host cells by facultative intracellular bacterial pathogens. In
addition, we discuss how the altered miRNAs help in the survival of these pathogens in
the intracellular environment.
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INTRODUCTION
Initially discovered in the nematode Caenorhabditis elegans in 1993 (Lee et al., 1993), miRNAs
are a non-coding class of RNAs which regulate the expression of protein coding genes post
transcriptionally either by degrading mRNA or by repressing translation. They are expressed by
eukaryotic and viral genomes and they range in size from 20 to 22 nucleotides in length (Bartel,
2009; Krol et al., 2010). Although their identification in different species still continues, themiRNAs
already identified have shown striking sequence conservation across species and phyla, suggesting
possible similarities in function among them as well. In humans, over 2500 matured miRNAs
(miRBase.org) have been identified so far and it is estimated that ∼60% of the human protein
coding genes are regulated by miRNAs (Friedman et al., 2009). Interestingly, however, since
miRNAs have the ability to interact with multiple mRNAs, the number of mRNAs regulated by
a single miRNA as well as the number of miRNAs by which a single mRNA can be regulated may
vary greatly (Krol et al., 2010).
A number of studies have focused on the different aspects of miRNA synthesis. miRNA is first
synthesized as a primary precursor, or pri-miRNA, by RNA polymerase II (Borchert et al., 2006).
Subsequently, this pri-miRNA gets processed into miRNA by two enzymes of the RNAse III family,
namely Drosha and Dicer, which are located in the nucleus and in the cytoplasm, respectively.
While Drosha cleaves the pri-miRNA into a 70 bp pre-miRNA hairpin structure (Lee et al., 2003),
Dicer cleaves this further into a 20–22 bp miRNA duplex. This duplex consists of a guide strand
and a messenger strand in which the messenger strand ultimately gets degraded. Following the
degradation of the messenger strand, the guide strand becomes matured miRNA and gets loaded
into the RNA induced silencing complex (RISC) which consists of Ago2 and other proteins such
as Tar RNA binding protein (TRBP) and KH type splicing regulatory protein (KSRP) (Wang
et al., 2009). Finally, RISC (loaded with the guide strand) binds with complementary sequences
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in the 3′-UTR of the target mRNA transcripts (protein coding
mRNA sequences) and inhibits their translation or leads to their
degradation (Bartel, 2009). The specificity of the target sequences
is determined by the 6-8 nucleotide “seed region” located at
the 5′-end of miRNA. Intriguingly, miRNAs are found in body
fluids such as serum, plasma, saliva, milk, and urine (Weber
et al., 2010). Although most of these miRNAs are bound to
Ago2 and are believed to be released by dead cells (Turchinovich
et al., 2011), isolation of exosome bound miRNAs suggests the
possibility that theymay be secreted out of the cells instead (Singh
et al., 2015).
It is now well-established that miRNAs play pivotal roles
in regulating cellular processes like cell proliferation, metabolic
pathways, immune response, and development (Bartel, 2004;
Kloosterman and Plasterk, 2006; Taganov et al., 2007; O’connell
et al., 2010; Deiuliis, 2016). Thus, expression of miRNAs at
normal levels is crucial for maintaining homeostasis in all
eukaryotes. Most importantly, alterations in the levels of cellular
miRNAs, due to either natural or unnatural causes, may have
a huge impact on life. Examples of this extensive impact are
genetic and epigenetic changes in the genome of humans
which alter miRNAs expression. These changes not only affect
cellular processes, but they also result in the manifestation of
life threatening diseases (Calin and Croce, 2006; Lawrie, 2007;
Saunders et al., 2007). Some serious diseases resulting from
altered miRNA expression in humans are cancer, kidney failure,
cardiac disease, diabetes, and liver cirrhosis (Kloosterman and
Plasterk, 2006; Rome, 2013; Finch et al., 2014; Santovito et al.,
2015; Trionfini et al., 2015). Notably, miRNAs released in bodily
fluids serve as biomarkers for diagnosis or treatment of certain
diseases (Guay and Regazzi, 2013; Mulrane et al., 2014; Pal et al.,
2015; Hayes and Chayama, 2016).
Altered expression of miRNAs also occurs when pathogens
infect their hosts, which includes humans, and this was first
observed in viral infections (Cullen, 2011). In addition to
modulating the expression of host miRNAs, several DNA viruses
like Herpes simplex virus are known to use their genome encoded
miRNAs to alter the expression of host mRNAs to increase their
pathogenicity (Gottwein and Cullen, 2008; Umbach et al., 2008).
Viruses like HIV-1 alter host miRNAs to maintain HIV-1 latency
in resting CD4+ T cells (Swaminathan et al., 2013). With respect
to bacteria, the very first evidence for miRNA alteration came
from infection of a plant, Arabidopsis thalina, by the bacterium
Pseudomonas syringae (Navarro et al., 2008). It was noted that
P. syringae infection of A. thalina upregulated the expression
of miR-393a, which in turn affected the receptors for auxin,
a negative regulator of plant defense. Following this report,
several groups initiated studies to assess the effects of bacterial
components such as lipopolysaccharide (LPS) and lipomannan
on themiRNAs ofmammalian cells or hosts (Tili et al., 2007; Xiao
et al., 2009; Rajaram et al., 2011). The fact that bacterial pathogens
have the ability to alter the host miRNAs is now well-defined
and experimentally verified by using disease causing pathogens
such as Helicobacter pylori, Listeria monocytogenes, Salmonella
enterica serovar Typhimurium, Mycobacterium tuberculosis and
others (Eulalio et al., 2012; Harapan et al., 2013; Staedel and
Darfeuille, 2013; Maudet et al., 2014a). These studies have also
unraveled that host cellular miRNAs are manipulated by bacterial
pathogens for their own survival. In this review, we specifically
focus on the manipulation of host miRNAs by intracellular
bacteria that belong to the genus Mycobacteria, Salmonella,
Listeria and Francisella.
MYCOBACTERIA
The genus Mycobacterium contains several intracellular
pathogens affecting humans and animals. While M. tuberculosis
and M. leprae are the etiological agents for the diseases
tuberculosis and leprosy in humans, M. bovis and M. avium are
pathogens associated with cattle tuberculosis and respiratory
illness in birds, respectively. Bacillus Calmette-Guérin (BCG)
is an attenuated strain of M. bovis and is an approved vaccine
against human tuberculosis (Andersen, 2001; Andersen and
Doherty, 2005). All these bacteria, including the vaccine strain
BCG, have the ability to survive in phagocytes. Since M.
tuberculosis is a serious cause of morbidity and mortality, this
pathogen is a relatively better studied organism than other species
of Mycobacteria. It gains entry into macrophages or phagocytes
by receptor mediated endocytosis; primarily through mannose
receptors located on the surface of phagocytes (Schlesinger
et al., 1994, 1996; Fenton et al., 2005). After gaining entry, the
endocytosed bacteria modulate or reprogram the maturation of
phagosomes using cell wall components and secreted products, a
process known as “phagosome maturation arrest” (Vergne et al.,
2004a,b, 2005). Essentially, the “phagosome maturation arrest”
is characterized by the arrest in the recruitment of molecules
required for trafficking machinery and membrane fusion
which include Rab GTPases and Rab interacting factors. It was
frequently observed that M. tuberculosis containing phagosomes
acquire Rab5A GTPase but fail to acquire Rab5A effectors like
EEA1 and hVPS34 (Fratti et al., 2001, 2003). As a consequence,
the immature phagosomes containing M. tuberculosis do not
fuse with lysosomes, which allow the bacteria to escape from the
toxic arsenals released by the lysosomal vacuoles.M. tuberculosis
within phagosomal compartments not only survives, but also
replicates by utilizing the host’s biomolecules as nutrients. In
addition, M. tuberculosis modulates cell death pathways like
apoptosis, necrosis, and autophagy to avoid the death of infected
cells (Moraco and Kornfeld, 2014).
Recently, several studies have explored the role of miRNAs
in mycobacterial infection (Harapan et al., 2013; Table 1).
However, a connection between miRNAs and phagosomal
formation/trafficking has been made in only a few of these
studies. Bettencourt et al. (2013) have obtained the first evidence
in this regard and reported thatM. tuberculosis infection induces
the expression of miR-142-3p in murine J774A.1 cells and in
primary human macrophages leading to the down regulation
of N-Wasp, an actin binding protein. The down regulation of
N-Wasp limits the amount of actin available for the formation
of actin filament in the early phagosome, thereby reducing the
uptake of M. tuberculosis pathogen. This was experimentally
confirmed by siRNA mediated knock down of N-Wasp in
human macrophages, indicating that miR-142-3p is one of the
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TABLE 1 | MicroRNAs altered by mycobacterial species or their proteins*.
Function miRNA Target Molecule altered Cell /Tissue examined Bacterial
Species/proteins
References
Phagocytosis miR-142-3p N-Wasp Actin J774A.1 and primary
human macrophages
M. tuberculosis Bettencourt et al.,
2013
Phagosomal
maturation
miR-15a
miR-21-3p
miR-22-3P
miR-23a
miR-30b-5p
miR-142-5p
Rab family of
proteins
Rab family of proteins Bovine alveolar
macrophages
M. bovis Vegh et al., 2015
NO Suppression miR-146a NF-κB, MAPK TRAF6 RAW264.7 macrophages
and BMDM
BCG Li et al., 2016
miR-155 C/EBPβ NO synthesis RAW264.7 macrophages M. marinum Qin et al., 2016
Apoptosis let-7e
miR-29a
Caspase 3
Caspase 7
Caspase 3
Caspase 7
Human monocyte derived
macrophages
M. avium Sharbati et al.,
2011
miR-21 NF-κB Bcl-2 RAW264.7 macrophages M. tuberculosis
MPT64
Wang Q. et al.,
2014
miR-155 FOXO3 Human monocytes, THP-1
cells
M. tuberculosis Huang et al., 2015
miR-582-5p FOXO1 Human monocytes M. tuberculosis Liu et al., 2013
Autophagy miR-17-5p ULK-1 ULK-1 RAW264.7 macrophages BCG Duan et al., 2015
miR-17-5p Mcl-1/STAT3 Beclin-1 RAW264.7 macrophages
and BMDM
M. tuberculosis Kumar et al., 2016
miR-30a Beclin-1 Human monocytes M. tuberculosis Chen et al., 2015
miR-33
miR-33*
ATG5, LAMP1 ATG5, ATG12,
LAMP1, LC3B,
AMPK, FOXO3 and
TEEB
Mouse peritoneal and
BMDM
M. tuberculosis Ouimet et al., 2016
miR-125a-3p UVRAG RAW264.7 macrophages
and BMDM
M. tuberculosis Kim et al., 2015
miR-3619-5p Cathepsin S Cathepsin S THP-1 macrophages BCG Pawar et al., 2016
Signaling Let-7f A20 NF-κB RAW264.7 macrophages
and BMDM
M. tuberculosis
ESAT-6
Kumar et al., 2015
miR-26a,
miR-132
P300 IFN-γ Human primary
macrophages
M. tuberculosis Ni et al., 2014
miR-124 TLR-6,
MyD88,
TNFR6, TNF-α
TLR-6, MyD88,
TNFR-AF6, TNF-α
Human peripheral
leukocytes
M. tuberculosis Ma et al., 2014a
Murine alveolar
macrophages, RAW264.7
macrophages, A549
epithelial cells
BCG Ma et al., 2014a,b
miR-146a IRAK-
1,TRAF-6
TNF-α, IL-1β, IL-6
and MCP-1
RAW264.7 macrophages BCG Li et al., 2013
miR-149 MYD-88 Inflammatory
mediators
RAW264.7 macrophages BCG Xu et al., 2014
miR-155 SHIP1,
SOCS1,
FADD, C/EBP-
β, NF-κB
Inflammatory
mediators, cytokines
Macrophages M. tuberculosis Rajaram et al.,
2011
RAW264.7 and mouse
BMDM
M. tuberculosis
ESAT-6
Kumar et al., 2012
(Continued)
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 August 2016 | Volume 6 | Article 79
Das et al. microRNAs Regulation by Pathogens
TABLE 1 | Continued
Function miRNA Target Molecule altered Cell /Tissue examined Bacterial
Species/proteins
References
Mouse peritoneal
macrophages
BCG Ghorpade et al.,
2012
RAW264.7 macrophages BCG Wang J. et al.,
2014
miR-223 IKKα subunit
of NF-κB
CCL3, CXCL2 and
IL-6
Human Blood and Lung
specimen
M. tuberculosis Dorhoi et al., 2013
Cytokines miR-26a IFN-γ IFN-γ Human macrophages M. tuberculosis Ni et al., 2014
miR-29 IFN-γ IFN-γ Mouse CD4+ and CD8+ T
cells
BCG Ma et al., 2011
miR-99b Genes for
TNF-α and
TNFRSF-4
receptors
TNF-α and
TNFRSF-4
Dendritic cells and
macrophages
M. tuberculosis Singh et al., 2013
miR-125b TNF-α TNF-α Macrophages M. tuberculosis Rajaram et al.,
2011
miR-132 P300 IFN-γ Human macrophages M. tuberculosis Ni et al., 2014
miR-144* IFN-γ, TNF-α Human blood M. tuberculosis Liu et al., 2011
miR-206 TIMP3 Cytokines, MMP THP-1 macrophage M. tuberculosis Fu et al., 2016
Antimicrobial
peptides
miR-21 Human monocytes Biopsy
from Leprosy patients
M. leprae Liu et al., 2012
Antigen
presentation
miR-381-3p CD1c T cell responses Human dendritic cells BCG Wen et al., 2016
*Indicates that only miRNAs with known functions are listed.
key miRNAs modulated by mycobacteria to gain entry into
macrophages. Additionally, this observation gains support from
previous studies which report that virulentM. tuberculosis blocks
actin filament assembly to facilitate its survival inside the host cell
(Anes et al., 2003).
In addition to the uptake process, miRNAs involvement in
endo-lysosomal pathways of mycobacteria has also surfaced.
This includes miRNAs miR-15a, miR-21-3p, miR-22-3P, miR-
23a, miR-30b-5p, and miR142-5p which get upregulated in
bovine alveolar macrophages in response to M. bovis infection
(Vegh et al., 2015). It was predicted that these miRNAs
target genes of the Rab family of membrane trafficking
proteins like Rab4a, Rab5b, Rab5c, and Rab7a, Rab11, and
Rab22a and modulate them to prevent phagosome maturation,
thus enabling mycobacteria to survive within phagosomes.
As noted, a key feature of mycobacterial phagosomes is the
acquisition of the early endosomal marker Rab5 and lack
of acquisition of late endosomal marker Rab7 (Via et al.,
1997). An additional feature of mycobacterial phagosomes is
the recruitment of copious amounts of Rab22a as compared
to other phagosomes (Roberts et al., 2006). As the miRNAs
reported by Vegh et al. target all of the important Rab
proteins associated with mycobacterial phagosomes, future
studies assessing the relationship between the above miRNAs
and Rab genes may provide valuable insights into the role
of miRNAs in the prevention of mycobacterial phagosome
maturation.
Furthermore, evidence that mycobacteria modulate miRNAs
to prevent apoptosis is also presented. To inhibit apoptosis, M.
tuberculosis upregulates the expression of miR-582-5p and miR-
155 and both of these miRNAs showed elevated expression in
the monocytes of tuberculosis patients in comparison to healthy
controls. In vitro reporter assays confirmed that miR-582-5p
and miR-155 down regulate the transcription factors FOXO1
and FOXO3, respectively, to inhibit apoptosis in these cells (Liu
et al., 2013; Huang et al., 2015). An M. tuberculosis secretory
protein MPT64 has also been implicated in the prevention of
apoptosis by acting upon Bcl2 through miR-21(Wang Q. et al.,
2014). M. avium, on the other hand, upregulates miRNAs let-
7e and miR-29a in human monocyte derived macrophages with
concomitant decrease in the expression of apoptosis associated
proteins caspase 3 and caspase 7 (Sharbati et al., 2011). Reporter
assays again revealed that let-7e and miR-29a target mRNA of
caspase 3 and caspase 7, respectively, to down regulate their
expression (Sharbati et al., 2011).
Although autophagy is primarily a cellular recycling process,
emerging evidences suggest that it is also a cellular defense
mechanism (Jo et al., 2013). M. tuberculosis partly evades
autophagy using the secretory proteins ESAT-6 and CFP-10
encoded by the ESX1 locus (Zhang et al., 2012) and the
cell wall lipid lipoarbinomannan (LAM) (Shui et al., 2011).
Recent studies show that M. tuberculosis modulates multiple
miRNAs to evade autophagy of infected macrophages. Duan
et al. (2015) have reported that BCG prevents the formation
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of autophagosomes by altering the expression of miR-17-
5p. RAW264.7 macrophages infected with BCG upregulates
the expression of miR-17-5p which in turn leads to the
down regulation of its target, ULK, a protein which regulates
autophagosome formation. In contrast, Kumar et al. (2016) have
reported that M. tuberculosis downregulates the expression of
miR-17-5p in infected macrophages and this is accompanied
by upregulation of its target proteins Mcl-1 and STAT3, a
transcriptional regulator of Mcl-1. Mcl-1 in turn interacts with
beclin-1 to inhibit autophagy and evidence in this regard has
been presented (Kumar et al., 2016). It is not known, however,
why BCG upregulates and M. tuberculosis downregulates miR-
17-5p in macrophages to prevent autophagy. On the other
hand, Kim et al. (2015) have noticed upregulation of miRNA-
125a-3p in M. tuberculosis infected macrophages. MiRNA-125a-
3p targets UV radiation resistance-associated gene (UVRAG)
in order to prevent autophagy and this was experimentally
verified by overexpressing miR-125a-3p or UVRAG protein
in macrophages and using inhibitors against miR125a-3p. A
third miRNA implicated in the inhibition of autophagy by M.
tuberculosis is miR-30a and this was predicted to act upon beclin-
1 since monocytes isolated from tuberculosis patients exhibited a
negative correlation between the concentrations of miR-30a and
beclin-1 (Chen et al., 2015). Incidentally, we have shown that
miRNA-30a is differentially expressed in THP-1 cells infected
with M. tuberculosis (Das et al., 2013). Further, a recent study
has noticed that M. tuberculosis upregulates miR-33 and its
precursor miR-33∗ in macrophages to inhibit autophagy (Ouimet
et al., 2016). Upregulation of miR-33 and miR-33∗ leads to the
repression of several key autophagy effector molecules such as
ATG5, ATG12, LAMP1, LC3B, AMPK, and FOXO3 and this
was verified by silencing of miR-33 and miR-33∗ by genetic and
pharmacological means; thus suggesting thatmiR-33 inhibition is
an important pathway to prevent autophagy by M. tuberculosis.
Another study has reported (Pawar et al., 2016) that BCG
downregulates the expression of miR-3619-5p leading to the
upregulation of its target protein cathepsin S (CTSS), which is a
lysosmal cysteine protease. It has been observed that inhibition of
CTSS expression enhances autophagy in different cells (Zhang L.
et al., 2014) and it is likely, therefore, that upregulation of CTSS
by BCG through miR-3619-5p could prevent autophagy.
Mycobacteria also modulate miRNAs associated with
signaling pathways which enhance their survival inside hosts.
MiR-155 targets multiple proteins such as SHIP1, SOCS1, FADD,
and C/EBP-β in the innate immune signaling pathways and
alters the expression of inflammatory mediators. Its expression
is upregulated in macrophages upon infection by both M.
tuberculosis and BCG (Rajaram et al., 2011; Sharbati et al., 2011;
Ghorpade et al., 2012; Kumar et al., 2012; Wang et al., 2013;
Wang J. et al., 2014). Although this upregulation occurs primarily
due to the sensing of the pathogens by TLRs of macrophages,
the secreted ESAT-6 protein of M. tuberculosis also seems to
contribute to the induction of miR-155 asM. tuberculosismutant
strain lacking in ESAT-6 has shown relatively less induction
of miR-155 in macrophages than the wild type strain (Kumar
et al., 2012). According to Kumar et al. the inhibition of miR-155
in RAW264.7 and murine bone marrow derived macrophages
(BMDM) affects the survival of M. tuberculosis in these cells. In
contrast, Ghorpade et al. (2012) have noted that BCG mediated
upregulation of miR-155 leads to apoptosis of the infected
cells through NF-κB signaling. Upregulated miR-155 has also
been noticed to be detrimental for mycobacteria as it induces
autophagy by repressing the Rheb and mTOR signaling pathways
(Wang et al., 2013). Furthermore, miR-155 upregulation has
been shown to increase the synthesis of TNF-α through the
SHIP1 pathway (Rajaram et al., 2011). Considering all these
negative effects, it remains highly unexplainable how miR155’s
function benefits the survival of mycobacteria inside the host.
Nevertheless, it appears that mycobacteria do have mechanisms
to counter the negative effects of miR-155 and make it beneficial
for their survival. For instance, lipomannan of the cell wall ofM.
tuberculosis can inhibit TNF-α synthesis and counteract the effect
of miR-155 upregulation (Rajaram et al., 2011). Additionally,
M. tuberculosis has been shown to induce miR-125b which
directly targets the mRNA of TNF-α (Rajaram et al., 2011). This
can reduce TNF-α synthesis and balance the effect of miR-155
upregulation.
Recently, Kumar et al. (2015) have found that M. tuberculosis
down regulates the expression of miRNA let-7f, which targets
mRNA of A20, an inhibitor of NF-κB. Significantly, the down
regulation of let-7f is accompanied by concomitant upregulation
of A20 in mice infected withM. tuberculosis (Kumar et al., 2015).
Additionally, M. tuberculosis fails to survive in macrophages
deficient in A20. These observations provide strong evidence
that M. tuberculosis uses let-7f to increase its survival inside the
host by inhibiting NF-κB through the expression of A20. This is
highlighted by the additional observation that down regulation
of let-7f is dependent upon ESAT-6, which is a major virulence
factor ofM. tuberculosis. In addition, mycobacterial infections of
macrophages were also found to induce significant levels of miR-
146a expression in a time and dose-dependent manner (Li et al.,
2013). This miRNA targets two key molecules involved in the
TLR/NF-κB signaling pathway cascades: interleukin-1 receptor-
associated kinase-1 (IRAK-1) and TNF receptor-associated
factor-6 (TRAF-6). It is likely that the increased expression
of miR-146a during M. tuberculosis infection will affect the
TLR/NF-κB and IRAK-1 pathways and as a consequence the
induction of proinflammatory cytokines TNF-α, IL-1β, IL-6, and
chemokineMCP-1 will be reduced. Another miRNA that behaves
in a similar fashion as miR-146a is miR-223 which modulates
the IKKα subunit of NF-κB and regulates the inflammatory
responses in mononuclear phagocytes. MiR-223 is significantly
upregulated in the blood and lungs of tuberculosis patients and
in the blood of mice infected with M. tuberculosis (Dorhoi et al.,
2013). Also, it appears that M. tuberculosis suppresses CCL3,
CXCL2, and IL-6 by upregulating the levels of miR-223 as these
are its direct targets. Lastly, it was also noticed that a knockout
mouse lacking in miR-223 (miR-223 −/−) was found to be
susceptible toM. tuberculosis infection (Dorhoi et al., 2013).
It is well-known that IFN-γ plays a critical role in resisting
intracellular infection. BCG regulates IFN-γ in mouse CD4+
and CD8+ T cells by downregulating the expression of miR-
29 (Ma et al., 2011) and M. tuberculosis regulates IFN-γ
in human macrophages by upregulating the expression of
miR-26a and miR-132 (Ni et al., 2014). Although, miR-29
targets IFN-γ directly, miR-26a and miR-132 target IFN-γ via
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P300, a transcription mediator. However, there is a significant
difference between the regulation of IFN-γ by miR-29 and
miR26a/132. Whereas down regulation of miR-29 leads to
increased expression of IFN-γ levels in CD4+ and CD8+ T cells,
upregulation of miR-26a/132 leads to the repression of IFN-
γ levels. The repression of IFN-γ in CD4+ and CD8+ T cells
by virulent M. tuberculosis may be a strategy for its survival
inside the host. Further, the differential regulation of IFN-γ by
M. tuberculosis and BCG, through different miRNAs, may reflect
the differences in their genes/proteins contents. On the other
hand, M. tuberculosis controls the levels of TNF-α in dendritic
cells andmacrophages throughmiR-99b. Both dendritic cells and
macrophages infected with M. tuberculosis show upregulation
of miR-99b and experimental down regulation of this miRNA
affects the growth of M. tuberculosis in these cells (Singh et al.,
2013). Further, inhibition of miR-99b augment the production
of TNF-α and TNFRSF-4 in these cells, suggesting that miR-
99b targets TNF-α and TNFRSF-4 receptor genes to control the
production of TNF-α and TNFRSF-4. Overall, this emphasizes
that upregulation of miR-99b by M. tuberculosis is critical
for its survival inside host cells. Additionally, M. tuberculosis
regulates IFN-γ and TNF-α in human T cells through miR-
144∗ and it is upregulated in the blood samples of TB patients.
In vitro transfection studies of T-cells with miR-144∗ indicated
that this miRNA could alter the levels of IFN-γ and TNF-
α production (Liu et al., 2011), suggesting that miR-144∗ is
associated with anti-TB immunity. Furthermore, it was also
noticed that the expression of miR-206 is markedly upregulated
in M. tuberculosis infected THP-1 cells and that upregulated
miR-206 positively regulates the inflammatory cytokines IL-1β,
IL-6, IFN-γ, TNF-α, and MMP9 (Fu et al., 2016). This may
indicate that miR-206 is the key regulator of inflammation during
M. tuberculosis infection and may be a potential therapeutic
target.
Mycobacteria can also modulate toll-like receptors (TLRs)
through miRNAs to reduce proinflammatory responses. MiR-
124, which directly controls TLR6, myeloid differentiation
factor 88 (MyD88), TNFR-associated factor 6 and TNF-α, is
upregulated in patients with pulmonary tuberculosis (Ma et al.,
2014a). Its expression is also elevated in BCG infected murine
alveolar macrophages, RAW264.7 macrophage cell line (Ma
et al., 2014a), and alveolar epithelial cell line A549 (Ma et al.,
2014b). Therefore, the upregulation of miR-124 in tuberculosis
patients and in the cells may be associated with regulation of
proinflammatory responses. However, BCG dynamically reduces
the expression of miR-149 in RAW264.7 cells with simultaneous
increase in the expression of MyD88 (Xu et al., 2014). Using a
luciferase reporter assay and immunoblotting against MyD88,
this study identified that miR-149 directly targets the 3′-UTR of
MyD88mRNA and BCGmediated increase inMyD88 expression
is linked to the increased production of inflammatory mediators
NF-κB1, TNF-α, and IL-6. Lastly, a recent study has noted
that BCG downregulates TLR-2 activated signaling events by
upregulating the expression of Sonic Hedgehog (SHH) receptors
(Ghorpade et al., 2013). This study speculates that this effect
could be due to miR-31 and miR-150 which target MyD88, an
adaptor protein of TLR2 signaling.
In order to kill invading pathogens, macrophages and
other phagocytes generate superoxide (O2
−) and nitric oxide
(NO) through membrane bound NADPH oxidase (NOX2)
and inducible nitric acid synthase (iNOS2), respectively (Ehrt
and Schnappinger, 2009). Mycobacteria avoid killing by these
reactive species by internalizing through specific receptors
(Schlesinger et al., 2008). In particular, M. tuberculosis seems to
use mannose receptors to escape from the bactericidal effects
of superoxide (Astarie-Dequeker et al., 1999). Although no
mycobacteria altered miRNA is implicated in the modulation
of O2
− generation in macrophages, a recent study has reported
that BCG can alter NO synthesis in macrophages through
miR-146a (Li et al., 2016). It was observed that miR-146a
expression in RAW264.7 andmouse BMDM is induced following
infection with BCG in a dose dependent manner, which in
turn suppresses the expression of iNOS indirectly by silencing
TRAF-6mRNA. Further, inhibition of endogenousmiR-146a was
noticed to enhance the NO production and consequently BCG
clearance, thus providing a direct a relationship between miR-
146a induction and BCG survival in macrophages. It is worth
noting here that this is the first report to link the modulation
of oxidative stress in host cells by a bacterium through miRNA.
Additionally, it has been reported that M. marinum survival in
macrophages is increased by miR-155 mediated suppression of
NO (Qin et al., 2016).
CD1c is an important lipid antigen presenting glycoprotein in
dendritic cells (DCs). Studies have already reported that CD1c
levels in M. tuberculosis infected DCs cells are greatly reduced
and this prevents the presentation of Mtb antigens to T cells
(Stenger et al., 1998; Gagliardi et al., 2007). A recent study has
unveiled that M. tuberculosis causes this by upregulating the
expression of miR-381-3p (Wen et al., 2016) and this study has
noted that DCs of TB patients had elevated expression of miR-
381-3p and this had an inverse relationship with CD1c. This
relationship was further explored in vitro by infecting DCs with
BCG which not only complemented the findings in TB patients,
but also revealed that suppression of antigen presentation in BCG
infected DCs could be reversed by inhibiting miR-381-3p. These
results may imply that miRNAs can be exploited in designing
future vaccines against TB.
M. leprae is a difficult organism to study because of its non-
cultivability under laboratory conditions. Nevertheless, a study
has reported differentially expressed miRNAs in the skin lesions
from tuberculoid leprosy and lepromatous leprosy (Liu et al.,
2012). This study has noticed that miR-21 was upregulated in the
skin lesions of lepromatous leprosy and in monocytes infected
with M. leprae. MiR-21 suppresses the expression of vitamin
D-dependent antimicrobial peptides CAMP and DEFB4 and
upregulation of miR-21 was thought to help M. leprae evade
antimicrobial response. Overall, Mycobacteria alter multiple
miRNAs to modulate the host response to infections.
SALMONELLA
S. enterica serovar Typhimurium is a food-borne pathogen
of both animals and humans (Cossart and Sansonetti, 2004)
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that causes the disease gastroenteritis. Salmonella invades
gastrointestinal epithelial cells, reaches the submucosa
through transcytosis, and gets phagocytosed by phagocytes
of the submucosal region. In intestinal epithelial cells and in
phagocytes, Salmonella survives intracellularly in the so-called
Salmonella containing vacuoles (SCVs) (Francis et al., 1993;
Garcia-Del Portillo and Finlay, 1994). In general, Salmonella
pathogenicity islands (SPIs) play critical roles in invasion,
internalization, and survival of Salmonella inside host cells.
Although Salmonella possesses five (SPI-1 to SPI-5) SPIs, SPI-1
contains the genes needed to encode the effector proteins
required for the invasion of Salmonella to epithelial cells
(Fabrega and Vila, 2013). SPI-1 also has genes to code for
proteins associated with a type III secretion system (T3SS)
which actually translocate the effector proteins into the host
cells. Proteins encoded by SPI-2 and the virulence plasmid
pSLT are essential for the survival of Salmonella within SCVs.
Similar to that of M. tuberculosis containing phagosomes, the
maturation and trafficking of SCVs are arrested by the effector
molecules released by the Salmonella within SCVs. Two effector
proteins SigD and SsaB seem to play pivotal roles in this process.
Whereas SigD modulates phosphoinositides of the membrane
to arrest vesicular trafficking (Hernandez et al., 2004), SsaB
inactivates the Hook3 component of the endocytic vesicle
which eventually disrupts the fusion of SCVs with lysosomes
(Uchiya et al., 1999).
In vitro studies indicate that Salmonellamodulates miRNAs in
both epithelial cells and macrophages (Schulte et al.; Table 2). It
was noticed that let-7a was downregulated in Salmonella infected
RAW264.7 and HeLa cells and miR-21, miR-146, and miR-155
were upregulated in RAW264.7 cells. Intriguingly, none of these
miRNAs showed any association with Salmonella’s invasion,
intracellular replication, or both, as mutant Salmonella strains for
these phenotypes had no effect on these miRNAs. It is not clear
that miRNAs specific for invasion and intracellular survival of
Salmonella do not exist or remain to be identified. The repression
of let-7a was found to be triggered by lipopolysaccharide (LPS),
through TLR4 sensing, to relieve its targets IL-6 and IL-
10 from negative posttranscriptional control. Both IL-6 and
IL-10 are associated with pro- and anti-inflammatory responses,
respectively, (Klimpel et al., 1995) and they more than likely play
a role in balancing the inflammatory response.
Recently, Maudet et al. (2014b), using a library of miRNA
mimics, has noticed that Salmonella downregulates the
expression of miR-15 family in HeLa cells. These miRNAs target
Cyclin D1 protein associated with cell cycle and down regulation
of miR-15 family derepresses the expression of Cyclin-1. This
renders the cells to remain in G1/S phase, a growth phase that
favors intracellular replication of Salmonella. In addition to
miR-15, miR-30c, and miR-30e have also been implicated in
the intracellular survival of Salmonella (Verma et al., 2015).
Both of these miRNAs target Ubc-9 protein associated with
SUMOylation, a posttranslational modification required for
fundamental cellular processes.
Using the piglet model, Hoeke et al. (2013) have demonstrated
that miR-29a was upregulated in ileal samples. This upregulation
led to the down regulation of its target, caveolin-2, an inhibitor
of Rho GTPase CDC42 that is associated with cytoskeletal
structures. Experimental down regulation of caveolin-2 increased
the uptake of Salmonella inside the cells, suggesting that
modulation of miR-29a is critical for Salmonella infection. On the
other hand, whole blood of piglets infected with Salmonella has
shown up- and down regulation of several miRNAs of which two
miRNAs have been characterized (Bao et al., 2015). These two
miRNAs, miR-124 and miR-331-3p, target genes SLC11A1 and
PIGE-108A11.3 and VAV2, respectively, and products of these
genes are associated with the regulation of immune responses.
Moreover, Salmonella infection upregulates the expression of
miR-128 in mouse intestinal tissue. It targets macrophage colony
stimulating factor (M-CSF) to downregulate its expression, which
in turn leads to decreased recruitment of macrophages to clear
Salmonella infection (Zhang T. et al., 2014). A few other studies
have reported altered miRNAs expression following Salmonella
infection (Sharbati et al., 2012; Yao et al., 2015; Uribe et al.,
TABLE 2 | MicroRNAs altered by Salmonella species*.
Function miRNA Target Molecule altered Cell /Tissue examined Bacterial
Species
References
Signaling miR-155 SHIP1, SOCS1,
FADD, C/EBP- β,
NF-κB
Inflammatory mediators,
cytokines
RAW264.7 macrophages,
HeLa epithelial cells
S. typhimurium Schulte et al., 2011
Cytokines Let-7a IL-6 and IL-10 IL-6 and IL-10 RAW264.7 macrophages,
HeLa epithelial cells
S. typhimurium Schulte et al., 2011
Cell cycle miR-15 family Cyclin Cyclin HeLa cells S. typhimurium Maudet et al., 2014b
Posttranslational
Modification
miR-30c and
miR-30e
Ubc-9 Ubc-9 J774A.1 macrophages S. typhimurium Verma et al., 2015
Cytoskeletal structures miR-29A Caveolin-2 Rho GTPase CDC42 Piglet ileal samples S. typhimurium Hoeke et al., 2013
miR-128 M-CSF Mouse intestinal tissue S. typhimurium Zhang T. et al., 2014
Iron homeostasis miR-214 SLC11A1,
PIGE-108A11.3
SLC11A1, PIGE-108A11.3 Whole blood of piglets S. typhimurium Bao et al., 2015
Rho GTPase activation miR-231-3p VAV2 VAV2 Whole blood of piglets S. typhimurium Bao et al., 2015
* Indicates that only miRNAs with known functions are listed.
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2016) but their roles in immune response and other functions
is unclear. Interestingly, there are no reports on the subversion of
miRNAs associated with the prevention of the apoptosis pathway,
although Salmonella does have effector proteins that prevent
apoptosis of infected epithelial cells at an early stage (Fabrega and
Vila, 2013).
LISTERIA
L. monocytogenes is another food-borne intracellular pathogen
that causes listeriosis in humans, a disease characterized by severe
septicemia. Infection of Listeria in pregnant women results in
abortion or meningoencephalitis in the new born (Allerberger
and Wagner, 2010). Listeria has the ability, like Salmonella, to
survive and replicate in both phagocytic and non-phagocytic
cells (Pizarro-Cerdá et al., 2012). It uses scavenger receptors
for gaining entry into macrophages and receptors such as E
cadherin, Met, and C1qR for internalizing into the epithelial
cells. The surface proteins internalin A (InlA) and internalin
B (InlB) serve as ligands to host cell receptors and the ligand-
receptor interaction mediates the uptake of the bacteria. In
addition, Listeria secretes a cholesterol dependent cytolysin called
listeriolysin O (LLO) which has a dual function of inhibiting
the phagosome maturation and making pores in the phagosomal
membrane (Henry et al., 2006; Shaughnessy et al., 2006). Using
LLO, along with two lipases PI-PLC and PC-PLC, Listeria breaks
the phagosomal membrane and escapes into the cytosol (Smith
et al., 1995). It replicates in the cytosol and becomes motile by
utilizing host actin cytoskeletal machinery. A bacterial surface
protein, ActA, induces the assembly of actin to give it a tail
shape, called actin comet tail, and the actin based motility enables
the bacterium to spread to neighboring cells (Lambrechts et al.,
2008).
Schnitger et al. (2011) infected macrophages with wild type
and LLO deficient L. monoctytogenes in parallel and analyzed the
expression of miRNAs in the infected cells to identify the host
miRNAs subverted by Listeria (Table 3). Although the infection
of macrophages by Listeria upregulated the expression of five
miRNAs, which include miR-155, miR-146a, miR-125a-3p/5p,
and miR-149, surprisingly the upregulated miRNAs remained
similar with both wild type and LLO deficient L. monocytogenes,
suggesting that miRNAs only play a limited regulatory role in the
inhibition of maturation of listeria containing phagosomes or in
the actin tail assembly in the infected cells. Infection of intestinal
epithelial Caco-2 cells with these strains also exhibited alteration
in the expression of miRNAs by both strains (Izar et al., 2012).
In this case, miR-146b, miR-16, and miR-155 were upregulated
and let-7a1 and miR-145 were down regulated. Interestingly,
some of these miRNAs were also found to be upregulated by
treating the cells with purified LLO alone. However, the miR-
155 was down regulated in epithelial cells infected with L.
monocytogenes deficient in internalin A and B as compared to
wild type infected cells, possibly suggesting that this strain could
induce less inflammatory response in the host.
Oral infection of mice with L. monocytogenes also showed
modulation of miRNAs. One study has observed that three
miRNAs (miR-192, miR-200b, and miR-215) were repressed in
the intestinal tissues after orally infecting humanized mice with
L. monocytogenes (Archambaud et al., 2012). But in conventional
mice, Listeria infection decreased the expression of 6 miRNAs
in which five (miR-143, miR-148a, miR-200b, miR-200c, and
miR-378) showed variations in expression in response to the
presence or absence of microbiota in the gut (Archambaud et al.,
2013). In addition, it was noticed that systemic infection of
L. monocytogenes down regulated the expression of miR-29 in
natural killer cells (NK cells) (Ma et al., 2011). MiR-29 represses
INF-γ expression and its down regulation is expected to increase
INF-γ levels in the host leading to resistance to infection. It is not
clear, however, how L. monocytogenes circumvents the effect of
INF-γ and survives inside the host.
FRANCISELLA
Francisella are gram negative cocci and facultative intracellular
pathogens. Francisella tularensis is the most virulent species
and the causative agent of “tularensis” in humans. Other
species in this genus like F. novicida and F. philomiragia are
non-pathogenic species and infect only immunocompromised
individuals. Francisella uses multiple receptors to gain entry
into macrophages (Celli and Zahrt, 2013). Following uptake,
the phagosomes containing Francisella acquires maturation
markers such as CD63, LAMP-1 and Rab7 but yet fail to
TABLE 3 | MicroRNAs altered by Listeria*.
Putative
Function
miRNA Target Molecule altered Cell /Tissue
examined
Bacterial Species Reference
Signaling miR-146a IRAK-1, IRAK-2
TRAF-6
TNF-α, IL-1β, IL-6 and
MCP-1
Macrophages L. monocytogenes Schnitger et al., 2011
miR-155 SHIP1, SOCS1,
FADD, C/EBP-
β, NF-κB
Inflammatory mediators,
cytokines
Macrophages L. monocytogenes Schnitger et al., 2011
Cytokines miR-223 IKKα subunit of
NF-κB
CCL3, CXCL2 and IL-6 Macrophages L. monocytogenes Schnitger et al., 2011
miR-29 IFN-γ IFN-γ Macrophages L. monocytogenes Ma et al., 2011
*indicates that only miRNAs with known functions are listed.
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FIGURE 1 | Schematic illustrating the miRNAs altered by Mycobacteria, Salmonella, Listeria and Francisella in relation to their cellular functions. The
functions are grouped under three major categories such as macrophage defense, immune response and other related processes. Only very few miRNAs altered by
these pathogens have shown common cellular functions and this includes miR-155. MiRNAs altered by specific pathogen(s) and their color(s) are as follows:
Black-Mycobacteria; Blue-Listeria; Light Red- Mycobacteria and Listeria; Deep Red-Salmonella; Green-Mycobacteria, Salmonella, Listeria and Francisella.
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fuse with lysosomes (Clemens et al., 2004; Santic et al.,
2005a,b; Chong et al., 2008; Wehrly et al., 2009). The
bacteria later escape from the phagosomal vacuole to the
cytoplasm via unknown mechanisms, possibly by disrupting
the membrane of the phagosomes. It is believed that the
phagosomal escape is necessary for multiplication of the
bacterium in the cytosol. The intracellular events of Francisella
are controlled by effectors released by type VI secretion
system located in the Francisella pathogenicity island (FPI)
(Santic et al., 2005b; Barker et al., 2009; Wehrly et al.,
2009).
Since F. novicida has the ability to down regulate the
expression of SHIP, the known target of miR-155, in monocytes
and macrophages, Cremer et al. speculated that there might be
a relationship between miR-155 and SHIP during Francisella
infection (Cremer et al., 2009). Using a luciferase reporter
assay, they were in fact able to demonstrate the upregulation
of miR-155 and down regulation of SHIP in macrophages
following F. novicida infection. It was also observed that
virulent F. tularensis (A SCHU S4 strain) infected cells
had relatively lower upregulation of miR-155 than the non-
virulent F. novicida infected cells. This difference was attributed
to the virulent strain’s ability to suppress proinflammatory
responses. Nevertheless, the upregulation of miR-155 was later
demonstrated to be due to soluble factors released from
Francisella (Cremer et al., 2012). A recent study using F.
tularensis live vaccine strain (LVS) has reported that nine
miRNAs were upregulated and one was down regulated in
macrophages (Bandyopadhyay et al., 2014). MiR-155 is one of
the upregulated miRNAs in this study for which the function
is known. The roles of other upregulated miRNAs in the
pathogenesis of Francisella remain to be investigated.
CONCLUSION
Intracellular bacteria that can survive and replicate in phagocytic
cells are generally considered more sophisticated than other
pathogens since they have the ability to modulate the defense
cells of the immune system and make them their home for
survival and multiplication. Therefore, we speculated that these
pathogens could alter a large number of miRNAs in infected
cells as compared to non-intracellular pathogenic bacteria.
Unfortunately, all four intracellular bacteria species focused
here have shown only a limited number of altered miRNAs
in the infected cells or in the hosts (Figure 1). The number
of altered miRNAs by these bacteria in macrophages remain
more or less similar to the number of miRNAs in non-
phagocytic cells following H. pylori infection (Matsushima et al.,
2011). Moreover, the miRNAs altered by intracellular pathogens
show little relationship toward phagosomal maturation and
trafficking. In particular, none of the miRNAs up- or down
regulated with Salmonella or Listeria infections of macrophages
are related to phagosome maturation (Figure 1). This is very
surprising because it does not correlate with the multiple
effectors employed by these pathogens to alter phagosomal
maturation and trafficking. At present it is difficult to provide
a meaningful explanation as to why these pathogens and
their products do not alter the miRNAs associated with the
phagosome maturation process or pathways associated with
other bactericidal mechanisms of phagocytes. One explanation
is that the effectors of these pathogens do not need regulation
by miRNAs as they already have the capacity to directly
hijack host molecules. The other explanation may be that
the altered miRNAs may have the capacity; however, these
functions are yet to be determined. The latter possibility seems
plausible in view of a recent publication that implicates miR-
146a in the suppression of NO production in macrophages (Li
et al., 2016). Initially, BCG mediated upregulation of miR-146a
was attributed only to the alteration of cytokines like TNF-α
(Li et al., 2013), but it’s role in the suppression of NO has only
recently been established (Li et al., 2016). Lastly, considering
the fact that the miRNA field is still evolving and that miRNAs
have multiple mRNA targets, assessing the potential interactions
between altered miRNAs with the mRNAs of proteins associated
with specific bactericidal pathways may help shed light on this
issue.
It is very encouraging to note that studies aimed at
understanding the roles of miRNAs in bacterial infections have
been gaining momentum in recent years. Invariably, in many of
these studies, selected cell types were used for miRNA profiling,
even if the cells were derived from infected animals or humans.
Since miRNAs are expressed in a tissue and cell specific manner,
identifying miRNAs in a selected cell type limits our ability
to obtain a comprehensive picture of miRNAs altered by a
specific pathogen inside the host. Further, there have been recent
reports that gut commensal bacteria can influence the miRNA
profiles to a specific pathogen (Archambaud et al., 2013). This
is a concern as it complicates the interpretation of previous
findings. Despite these issues, studies on miRNAs associated
with intracellular bacteria and other pathogens are likely to
contribute to the development of therapeutics and biomarkers,
especially for those that cause chronic and deadly diseases likeM.
tuberculosis.
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